In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation

Rosemarie Krupar, Christian Watermann, Christian Idel, Julika Ribbat-Idel, Anne Offermann, Helen Pasternack, Jutta Kirfel, Andrew G. Sikora, Sven Perner

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation'. Together they form a unique fingerprint.

Medicine & Life Sciences